Satish Sankaran

Employment

• Farcast Biosciences Chief Scientific Officer
  2019 - Present
• OncoStem Diagnostics Senior Director
  2018 - 2019
• Strand LifeSciences VP & Lab Director
  2012 - 2018
• Abexome Biosciences Principal Architect
  2008 - 2012

Education

• Jawaharlal Nehru University PhD
  1996 - 2003

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer
  Nature Communications 2024 DOI: 10.1038/s41467-024-45723-z
  +Save
• ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms
  Cancer Immunology Research 2024 DOI: 10.1158/2326-6066.cir-23-0568
  +Save
• Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.
  BMC cancer 2020 DOI: 10.1186/s12885-020-07218-0
  +Save
• CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario.
  Indian journal of surgical oncology 2019 DOI: 10.1007/s13193-019-01014-4
  +Save
• Analysis of solid tumor mutation profiles in liquid biopsy.
  Cancer medicine 2018 DOI: 10.1002/cam4.1791
  +Save
• Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing.
  Ethiopian journal of health sciences 2018 DOI: 10.4314/ejhs.v28i2.5
  +Save
• Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
  Breast cancer research and treatment 2018 DOI: 10.1007/s10549-018-4726-x
  +Save
• Genetic variants in post myocardial infarction patients presenting with electrical storm of unstable ventricular tachycardia.
  Indian pacing and electrophysiology journal 2018 DOI: 10.1016/j.ipej.2018.01.003
  +Save
• StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.
  Cancer medicine 2017 DOI: 10.1002/cam4.1037
  +Save
• Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
  Molecular vision 2016
  +Save